De novo ceramide synthesis is required for n-linked glycosylation in plasma cells

Journal of Immunology

Volumn 182, Issue 11, 2009, Pages 7038-7047

  Goldfinger, Meidan ^a   Laviad, Elad L ^b   Hadar, Rivka ^a   Shmuel, Miri ^a   Dagan, Arie ^c   Park, Hyejung ^d,e   Merrill Jr , Alfred H ^d,e   Ringel, Israel ^a   Futerman, Anthony H ^b   Tirosh, Boaz ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c HEBREW UNIVERSITY   (Israel)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^e Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; FUMONISIN B1; GLYCEROPHOSPHOLIPID; LIPOPOLYSACCHARIDE; SPHINGOMYELIN; X BOX BINDING PROTEIN 1; DIHYDROCERAMIDE DESATURASE; DNA BINDING PROTEIN; FUMONISIN; OXIDOREDUCTASE; REGULATORY FACTOR X TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CELL EXPANSION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GLYCOSYLATION; LIPOGENESIS; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; METABOLISM;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CERAMIDES; DNA-BINDING PROTEINS; FUMONISINS; GLYCOSYLATION; LIPOPOLYSACCHARIDES; METABOLIC NETWORKS AND PATHWAYS; MICE; OXIDOREDUCTASES; PLASMA CELLS; TRANSCRIPTION FACTORS;

EID: 67449146868     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802990     Document Type: Article

References (51)

1. Calame, K. L., K. I. Lin, and C. Tunyaplin. 2003. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21: 205-230.
2. Klein, U., S. Casola, G. Cattoretti, Q. Shen, M. Lia, T. Mo, T. Ludwig, K. Rajewsky, and R. Dalla-Favera. 2006. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 7: 773-782.
3. Shapiro-Shelef, M., K. I. Lin, L. J. McHeyzer-Williams, J. Liao, M. G. McHeyzer-Williams, and K. Calame. 2003. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19: 607-620.
4. Reimold, A. M., N. N. Iwakoshi, J. Manis, P. Vallabhajosyula, E. Szomolanyi-Tsuda, E. M. Gravallese, D. Friend, M. J. Grusby, F. Alt, and L. H. Glimcher. 2001. Plasma cell differentiation requires the transcription factor XBP-1. Nature 412: 300-307.
5. Iwakoshi, N. N., A. H. Lee, P. Vallabhajosyula, K. L. Otipoby, K. Rajewsky, and L. H. Glimcher. 2003. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat. Immunol. 4: 321-329.
6. Gass, J. N., N. M. Gifford, and J. W. Brewer. 2002. Activation of an unfolded protein response during differentiation of antibody-secreting B cells. J. Biol. Chem. 277: 49047-49054.
7. Sriburi, R., S. Jackowski, K. Mori, and J. W. Brewer. 2004. XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. J. Cell. Biol. 167: 35-41.
8. van Anken, E., E. P. Romijn, C. Maggioni, A. Mezghrani, R. Sitia, I. Braakman, and A. J. Heck. 2003. Sequential waves of functionally related proteins are expressed when B cells prepare for antibody secretion. Immunity 18: 243-253.
9. Schroder, M., and R. J. Kaufman. 2005. The mammalian unfolded protein response. Annu. Rev. Biochem. 74: 739-789.
10. Shaffer, A. L., M. Shapiro-Shelef, N. N. Iwakoshi, A. H. Lee, S. B. Qian, H. Zhao, X. Yu, L. Yang, B. K. Tan, A. Rosenwald, et al. 2004. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21: 81-93.
11. Sriburi, R., H. Bommiasamy, G. L. Buldak, G. R. Robbins, M. Frank, S. Jackowski, and J. W. Brewer. 2007. Coordinate regulation of phospholipid biosynthesis and secretory pathway gene expression in XBP-1(S)-induced endoplasmic reticulum biogenesis. J. Biol. Chem. 282: 7024-7034.
12. Fagone, P., R. Sriburi, C. Ward-Chapman, M. Frank, J. Wang, C. Gunter, J. W. Brewer, and S. Jackowski. 2007. Phospholipid biosynthesis program underlying membrane expansion during B-lymphocyte differentiation. J. Biol. Chem. 282: 7591-7605.
13. Lee, A. H., E. F. Scapa, D. E. Cohen, and L. H. Glimcher. 2008. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320: 1492-1496.
14. Futerman, A. H., and H. Riezman. 2005. The ins and outs of sphingolipid synthesis. Trends Cell Biol. 15: 312-318.
15. Futerman, A. H., and Y. A. Hannun. 2004. The complex life of simple sphingolipids. EMBO Rep. 5: 777-782.
16. Mathias, S., L. A. Pena, and R. N. Kolesnick. 1998. Signal transduction of stress via ceramide. Biochem. J. 335: 465-480. (Pubitemid 28515396)
17. Zhang, Y., B. Yao, S. Delikat, S. Bayoumy, X. H. Lin, S. Basu, M. McGinley, P. Y. Chan-Hui, H. Lichenstein, and R. Kolesnick. 1997. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89: 63-72. (Pubitemid 27180586)
18. Wang, E., W. P. Norred, C. W. Bacon, R. T. Riley, and A. H. Merrill, Jr. 1991. Inhibition of sphingolipid biosynthesis by fumonisins: implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266: 14486-14490.
19. Merrill, A. H., Jr., D. C. Liotta, and R. T. Riley. 1996. Fumonisins: fungal toxins that shed light on sphingolipid function. Trends Cell Biol. 6: 218-223.
20. Parodi, A. J. 2000. Protein glucosylation and its role in protein folding. Annu. Rev. Biochem. 69: 69-93.
21. Rush, J. S., E. C. Snow, and C. J. Waechter. 1987. Induction of glycoprotein biosynthesis in activated B lymphocytes. Arch. Biochem. Biophys. 259: 567-575.
22. Riebeling, C., J. C. Allegood, E. Wang, A. H. Merrill, Jr., and A. H. Futerman. 2003. Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J. Biol. Chem. 278: 43452-43459.
23. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
24. Tirosh, B., N. N. Iwakoshi, L. H. Glimcher, and H. L. Ploegh. 2005. XBP-1 specifically promotes IgM synthesis and secretion, but is dispensable for degradation of glycoproteins in primary B cells. J. Exp. Med. 202: 505-516.
25. Back, S. H., M. Schroder, K. Lee, K. Zhang, and R. J. Kaufman. 2005. ER stress signaling by regulated splicing: IRE1/HAC1/XBP1. Methods 35: 395-416.
26. Ting, Y. L., D. Sherr, and H. Degani. 1996. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res. 16: 1381-1388.
27. Merrill, A. H., Jr., M. C. Sullards, J. C. Allegood, S. Kelly, and E. Wang. 2005. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 36: 207-224.
28. Stevens, R. H., B. A. Askonas, and J. L. Welstead. 1975. Immunoglobulin heavy chain mRNA in mitogen-stimulated B cells. Eur. J. Immunol. 5: 47-53.
29. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549.
30. Hetz, C., A. H. Lee, D. Gonzalez-Romero, P. Thielen, J. Castilla, C. Soto, and L. H. Glimcher. 2008. Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis. Proc. Natl. Acad. Sci. USA 105: 757-762.
31. Rickert, R. C., J. Roes, and K. Rajewsky. 1997. B lymphocyte-specific, Cremediated mutagenesis in mice. Nucleic Acids Res. 25: 1317-1318.
32. Hu, W., R. Xu, G. Zhang, J. Jin, Z. M. Szulc, J. Bielawski, Y. A. Hannun, L. M. Obeid, and C. Mao. 2005. Golgi fragmentation is associated with ceramide-induced cellular effects. Mol. Biol. Cell 16: 1555-1567.
33. Jayadev, S., J. C. Barrett, and E. Murphy. 2000. Elevated ceramide is downstream of altered calcium homeostasis in low serum-induced apoptosis. Am. J. Physiol. 279: C1640-C1647.
34. Shang, J., N. Gao, R. J. Kaufman, D. Ron, H. P. Harding, and M. A. Lehrman. 2007. Translation attenuation by PERK balances ER glycoprotein synthesis with lipid-linked oligosaccharide flux. J. Cell. Biol. 176: 605-616.
35. Malhotra, R., M. R. Wormald, P. M. Rudd, P. B. Fischer, R. A. Dwek, and R. B. Sim. 1995. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1: 237-243.
36. Omtvedt, L. A., L. Royle, G. Husby, K. Sletten, C. M. Radcliffe, D. J. Harvey, R. A. Dwek, and P. M. Rudd. 2006. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthritis Rheum. 54: 3433-3440.
37. Peyrieras, N., E. Bause, G. Legler, R. Vasilov, L. Claesson, P. Peterson, and H. Ploegh. 1983. Effects of the glucosidase inhibitors nojirimycin and deoxynojirimycin on the biosynthesis of membrane and secretory glycoproteins. EMBO. J. 2: 823-832.
38. Chung, J. B., M. A. Baumeister, and J. G. Monroe. 2001. Cutting edge: differential sequestration of plasma membrane-associated B cell antigen receptor in mature and immature B cells into glycosphingolipid-enriched domains. J. Immunol. 166: 736-740.
39. Pfeiffer, A., A. Bottcher, E. Orso, M. Kapinsky, P. Nagy, A. Bodnar, I. Spreitzer, G. Liebisch, W. Drobnik, et al. 2001. Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur. J. Immunol. 31: 3153-3164.
40. Futerman, A. H., B. Stieger, A. L. Hubbard, and R. E. Pagano. 1990. Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus. J. Biol. Chem. 265: 8650-8657.
41. van Meer, G. 1998. Lipids of the Golgi membrane. Trends Cell Biol. 8: 29-33.
42. Hanada, K., K. Kumagai, N. Tomishige, and M. Kawano. 2007. CERT and intracellular trafficking of ceramide. Biochim. Biophys. Acta 1771: 644-653.
43. Gardner, R. G., A. G. Shearer, and R. Y. Hampton. 2001. In vivo action of the HRD ubiquitin ligase complex: mechanisms of endoplasmic reticulum quality control and sterol regulation. Mol. Cell. Biol. 21: 4276-4291.
44. Giussani, P., M. Maceyka, H. Le Stunff, A. Mikami, S. Lepine, E. Wang, S. Kelly, A. H. Merrill, Jr., S. Milstien, and S. Spiegel. 2006. Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-Golgi trafficking of ceramide. Mol. Cell. Biol. 26: 5055-5069.
45. Takatsuki, A., and G. Tamura. 1971. Effect of tunicamycin on the synthesis of macromolecules in cultures of chick embryo fibroblasts infected with Newcastle disease virus. J. Antibiot. 24: 785-794.
46. Crick, D. C., J. R. Scocca, J. S. Rush, D. W. Frank, S. S. Krag, and C. J. Waechter. 1994. Induction of dolichyl-saccharide intermediate biosynthesis corresponds to increased long chain cis-isoprenyltransferase activity during the mitogenic response in mouse B cells. J. Biol. Chem. 269: 10559-10565.
47. Pittet, M., D. Uldry, M. Aebi, and A. Conzelmann. 2006. The N-glycosylation defect of cwh8Δ yeast cells causes a distinct defect in sphingolipid biosynthesis. Glycobiology 16: 155-164.
48. Martinez, J. A., J. J. Tavarez, C. M. Oliveira, and D. K. Banerjee. 2006. Potentiation of angiogenic switch in capillary endothelial cells by cAMP: a cross-talk between up-regulated LLO biosynthesis and the HSP-70 expression. Glycoconj. J. 23: 209-220.
49. 2+-ATPase from kidneypromixal tubule cells with protein kinase A as an intermediate. J. Biol. Chem. 282: 24599-24606.
50. Taylor, A. K., and R. Wall. 1988. Selective removal of alpha heavy-chain glycosylation sites causes immunoglobulin A degradation and reduced secretion. Mol. Cell. Biol. 8: 4197-4203.
51. Nuttall, J., J. K. Ma, and L. Frigerio. 2005. A functional antibody lacking Nlinked glycans is efficiently folded, assembled and secreted by tobacco mesophyll protoplasts. Plant Biotech. J. 3: 497-504.